NUTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nutex Health Inc (NUTX) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The financial performance is weak, with significant declines in revenue, net income, EPS, and gross margin. Technical indicators show a bearish trend with no strong buy signals, and there are no positive catalysts or news to support a bullish sentiment. The lack of trading trends and neutral sentiment from insiders and hedge funds further diminishes the appeal of this stock.
The MACD is positive at 1.84 but contracting, indicating weakening momentum. RSI is neutral at 47.046, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 87.501, and resistance is at 100.948. Overall, the technical indicators suggest a bearish trend with no clear buy signal.
NULL identified. No recent news or events to act as positive catalysts.
Significant declines in financial performance metrics, including revenue (-41.12% YoY), net income (-80.79% YoY), EPS (-82.47% YoY), and gross margin (-44.67% YoY). No recent insider or hedge fund activity to support the stock.
In Q4 2025, revenue dropped to $151.68M (-41.12% YoY), net income dropped to $11.83M (-80.79% YoY), EPS dropped to 1.56 (-82.47% YoY), and gross margin dropped to 30.42 (-44.67% YoY). These metrics indicate a significant deterioration in financial health.
No analyst rating or price target changes available.
